Connection

Djillali Annane to Drug Combinations

Back to Details
This is a "connection" page, showing publications Djillali Annane has written about Drug Combinations.
Djillali Annane
Connection Strength
0.080
Drug Combinations
  1. Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial. Intensive Care Med. 2021 Aug; 47(8):867-886.
    View in: PubMed
    Score: 0.028
  2. Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients. Eur J Clin Pharmacol. 2021 Mar; 77(3):389-397.
    View in: PubMed
    Score: 0.026
  3. Impact of medical care, including use of anti-infective agents, on prognosis of COVID-19 hospitalized patients over time. Int J Antimicrob Agents. 2020 Oct; 56(4):106129.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.